Casting and Splinting Market to Reach USD 6.89 Billion by 2032, Driven by Orthopedic Injuries and Advanced Immobilization Technologies

Market Estimation, Growth Drivers, and Opportunities

The global Casting and Splinting Market was valued at USD 3.89 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032, reaching nearly USD 6.89 billion by 2032. Casting and splinting products play an essential role in immobilizing and supporting fractures, sprains, and other musculoskeletal injuries, helping patients recover while limiting movement in affected areas.

Market growth is supported by the rising incidence of road accidents, sports injuries, and fractures associated with an aging population. Increasing access to orthopedic treatment, greater healthcare expenditure, and demand for effective injury-management solutions are also contributing to adoption across hospitals, clinics, and orthopedic care facilities. Traditional plaster products remain relevant, while fiberglass, thermoplastics, and other synthetic materials offer opportunities to improve strength, weight, comfort, and ease of application.

Technological advancement is creating additional opportunities for manufacturers. Lightweight and breathable casting materials, pre-cut splints, water-resistant solutions, and customized immobilization devices can improve patient comfort and treatment convenience. Three-dimensional (3D) scanning and printing also offer possibilities for patient-specific casts and splints. Companies that develop cost-effective products, simplify clinical workflows, and improve material sustainability could strengthen their position as healthcare providers seek effective solutions for acute injuries and rehabilitation.

* Gain Competitive Market Advantage: https://www.maximizemarketresearch.com/request-sample/46313/ 

US Market Trends and Investment

The United States remains an important market for casting and splinting products because of its established healthcare infrastructure, substantial demand for orthopedic care, and adoption of new medical technologies. In 2025, industry attention continued to focus on more comfortable, lightweight, and convenient immobilization products, alongside customized solutions for individual patients. The broader movement toward outpatient treatment and efficient emergency-care workflows creates opportunities for products that are easy to apply, adjust, and remove. Manufacturers can also pursue growth through research and development in synthetic materials, digital customization, and improved product designs. However, individual investment announcements and product launches should be verified through official company disclosures before being treated as confirmed market developments.

Market Segmentation: Leading Segments

By product type, Casting Supplies and Equipment held the leading market position in 2024. These products remain widely used in fracture treatment because they provide reliable immobilization and are supported by established clinical procedures. Casting tapes, plaster casts, cast cutters, and related accessories serve different stages of treatment, from application to removal. Demand for safer, more efficient cast-removal equipment also creates opportunities to improve clinical workflows.

By material type, the market includes polyester, polyethylene, and fiberglass. Fiberglass and other synthetic materials offer potential advantages in strength, weight, and patient convenience compared with traditional plaster. By end user, hospitals and clinics represent key demand centers because they provide emergency treatment, fracture management, orthopedic consultations, and follow-up care.

Casting and Splinting Market, Key Players
North America

1. Precision Castparts Corp. (PCC) – Portland, Oregon, USA
2. Textron Inc. – Providence, Rhode Island, USA
3. Nemak – Monterrey, Nuevo León, Mexico
4. Alcoa Corporation – Pittsburgh, Pennsylvania, USA
5. Parker Hannifin Corporation – Cleveland, Ohio, USA

Europe

1. Andritz Schuler GmbH – Göppingen, Germany
2. Goodwin plc – Stoke-on-Trent, England, UK
3. Georg Fischer AG (GF Casting Solutions) – Schaffhausen, Switzerland
4. Voestalpine AG – Linz, Austria
5. Idra Group – Travagliato, Italy

Asia Pacific

1. Gloria Material Technology Corp. – Tainan, Taiwan
2. Kobe Steel, Ltd. – Kobe, Japan
3. TADANO Ltd. – Takamatsu, Japan
4. ASMPT Limited – Singapore
5. Jebsen & Jessen Group – Singapore

Competitive Analysis: Key Companies and Innovation

The market report identifies several established suppliers competing through product portfolios, clinical distribution networks, material development, and product usability. It does not provide a verified ranking of the five companies by individual market share; the following are notable companies identified in the market landscape.

1. 3M Healthcare: Its Scotchcast portfolio includes fiberglass casting tapes, flexible casting materials, padding, and splinting products. Soft Cast products are designed to retain flexibility after curing, supporting selected treatment applications and patient mobility. 
2. BSN Medical, part of Essity: The Delta-Cast range covers synthetic casting, splinting, padding, and cast-removal solutions. In 2025, Essity highlighted its Delta-Cast Serene cast remover, designed to reduce noise and airborne particles while helping improve safety during cast removal. 
3. Stryker Corporation: Stryker is included among the report's key players. Its established medical-device presence and cast-removal-related offerings position it within the broader fracture-care ecosystem.
4. Prime Medical Inc.: Prime Medical is identified in the report's competitive landscape. Opportunities for suppliers in this category include developing accessible immobilization products and strengthening distribution to orthopedic practices and healthcare facilities.
5. AliMed: AliMed is another company listed in the report's key-player information. Its participation reflects demand for orthopedic and clinical-care supplies, where product availability, practical design, and provider support can influence purchasing decisions.

Competition is likely to increasingly favor companies that combine dependable traditional products with lighter materials, improved ventilation, easier application, and patient-specific solutions. However, the report does not establish market-share percentages for these individual companies.

Regional Analysis: United States, United Kingdom, Germany, France, Japan, and China

United States: The US benefits from established hospitals, orthopedic specialists, emergency-care services, and access to advanced medical products. The FDA's medical-device regulatory framework provides oversight for product safety and performance. Demand is supported by fracture treatment, sports injuries, and the adoption of synthetic casting and customized immobilization products. The report identifies North America as the largest regional market in 2024, but does not specify individual country shares.

United Kingdom: The UK's established National Health Service and network of trauma and orthopedic services support demand for casting and splinting products. Pressure to improve treatment efficiency and patient experience creates opportunities for comfortable, practical products and safer cast-removal technologies.

Germany: Germany's advanced healthcare system and strong medical-device sector support adoption of fracture-management solutions. The availability of established suppliers, including Essity's BSN medical business, helps sustain access to casting, splinting, and related products.

France: France's hospital infrastructure, orthopedic services, and rehabilitation pathways support demand for immobilization products. Opportunities include lightweight synthetic materials and solutions that improve comfort during treatment and recovery.

Japan: An aging population and established healthcare services contribute to demand for fracture care. Growing attention to age-related injuries and rehabilitation creates opportunities for easy-to-use, comfortable casting and splinting products.

China: Healthcare investment, expanding access to orthopedic treatment, and rising demand associated with road injuries and sports-related trauma support market opportunities. China is also part of the Asia-Pacific region, which the report expects to grow fastest as healthcare infrastructure and access continue to develop.

Related Reports: 

Global Gynecology Drugs Market https://www.maximizemarketresearch.com/market-report/global-gynecology-drugs-market/36456/ 

Global Gas Chromatography Systems Market https://www.maximizemarketresearch.com/market-report/global-gas-chromatography-systems-market/83319/ 

Global Oncology Information System Market https://www.maximizemarketresearch.com/market-report/global-oncology-information-system-market/6591/ 

Conclusion

The Casting and Splinting Market is positioned for sustained growth as orthopedic injuries, aging-related fractures, and demand for effective immobilization solutions support product use. With the global market projected to reach USD 6.89 billion by 2032, manufacturers have opportunities to combine reliable casting products with innovations in synthetic materials, safer removal systems, breathable designs, and customized 3D-printed devices. The strongest long-term opportunity lies in balancing patient comfort and clinical performance with affordability and accessibility. Companies that invest in practical innovation, support healthcare professionals, and expand distribution across established and emerging markets are well positioned to benefit from the industry's continued development.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com